Atlas Trials

Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms

Clinical trial NCT02606539 · UNKNOWN

Trial details

NCT number
NCT02606539
Sponsor
Maher elesawi kamel elesawi
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Gestational Trophoblastic Neoplasms
Start date
2015-09-01
Primary completion
2017-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.